‘Big Night Out’ Gone Bad: US FDA Says Instagram Post For Merz’s Xeomin Minimizes Risks, Overstates Efficacy

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".